latest news releases from the newsroom
Xlibris Releases a New Medical Suspense Novel That Will Leave Readers Breathless
DIXON, Calif., Oct. 9, 2006 (PRIMEZONE) -- When people's lives are at stake, there is little room for error and sacrifices are simply unavoidable. But in times of crisis, conflicts of interest often emerge and legal obstacles tend to hamper rescue or prevention efforts. A gripping tale of suspense and terror is about to begin and stun your imagination as Xlibris proudly releases CONTAMINATED, a compelling new book marking the writing debut of Cynda Monet.
GlobeOp Financial Services
GlobeOp Names Martin Veilleux Chief Financial Officer
NEW YORK and LONDON, Oct. 9, 2006 (PRIMEZONE) -- GlobeOp Financial Services (or GlobeOp(r)), a leading, independent financial technology specialist providing automated, integrated middle- and back-office, administration and risk reporting services to hedge funds and asset management firms -- including banks, insurance companies, pension funds and proprietary traders, today announced the appointment of Martin Veilleux as chief financial officer. Veilleux also has been named to GlobeOp's management committee and will be based in the Manhattan office.
SmallCap Sentinel: Waiting for the Breakthrough Deal
IRVINE, Calif., Oct. 9, 2006 (PRIMEZONE) -- "In a market populated by bright eyed companies with bold visions of market share and abundant success it is often difficult to discern those with staying power . . . and a real product line," stated SmallCap Sentinel analyst D.R. Clark. "It's even more difficult in more scientific fields like biotechnology as the average investor lacks the acumen to personally validate the company's core product line."
Actelion Ltd: Detailed Analysis of CONSCIOUS-1 Presented at CNS
CHICAGO and ALLSCHWIL, Switzerland, Oct. 9, 2006 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today that the detailed analysis of the dose-finding study CONSCIOUS-1 (Clazosentan to Overcome Neurological iSChemia and Infarct OccUrring after Subarachnoid hemorrhage) has been presented at the Congress of Neurological Surgeons (CNS) in Chicago by R. Loch Macdonald, MD, PhD, Professor of Surgery and Radiation & Cellular Oncology at University of Chicago Hospitals. Dr. Macdonald is a member of the study steering committee.